Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual-hormone Closed-loop Glucose Control in Type 1 Diabetes
NCT04053712Phase 4Completed
- Sponsor
- Steno Diabetes Center Copenhagen
- Start
- Jul 2019
- Primary completion
- Mar 2021
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of glucagon in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Steno Diabetes Center Copenhagen. Primary endpoints: Percentage of time with glucose values < 3.9 mmol/l at 33 hours and Number of carbohydrate interventions to treat hypoglycemia at 33 hours. Started Jul 2019; status: completed.
02
Drugs
glucagon
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT04053712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04053712.